Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary Forum on Drug Discovery, Development, and Translation, Leslie Pray, Rapporteur, ISBN: 0-309-10739-3, 98 pages, 6 x 9, (2007) This free PDF was downloaded from: http://www.nap.edu/catalog/11910.html
Visit the National Academies Press online, the authoritative source for all books from the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the National Research Council: • • • • •
Download hundreds of free books in PDF Read thousands of books online for free Purchase printed books and PDF files Explore our innovative research tools – try the Research Dashboard now Sign up to be notified when new books are published
Thank you for downloading this free PDF. If you have comments, questions or want more information about the books published by the National Academies Press, you may contact our customer service department toll-free at 888-624-8373, visit us online, or send an email to
[email protected] This book plus thousands more are available at www.nap.edu. Copyright © National Academy of Sciences. All rights reserved. Unless otherwise indicated, all materials in this PDF file are copyrighted by the National Academy of Sciences. Distribution or copying is strictly prohibited without permission of the National Academies Press . Permission is granted for this material to be posted on a secure password-protected Web site. The content may not be posted on a public Web site.
Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary http://www.nap.edu/catalog/11910.html
Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy Leslie Pray, Rapporteur
THE NATIONAL ACADEMIES PRESS Washington, D.C. www.nap.edu
Copyright © National Academy of Sciences. All rights reserved.
Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary http://www.nap.edu/catalog/11910.html
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. This study was supported by contracts between the National Academy of Sciences and the Department of Health and Human Services (Contract Nos. 223-01-2460, HHSP233200600500P, HHSP23320042509X1, HHSP2330060043OP, and N01-OD-42139), the Department of Veterans Affairs (Contract No. V101(93)P-2136), Abbott Laboratories, American Diabetes Association, American Society for Microbiology, Amgen, Inc., Association of American Medical Colleges, AstraZeneca Pharmaceuticals, Blue Cross Blue Shield Association, Burroughs Wellcome Fund, Doris Duke Charitable Foundation, Eli Lilly and Company, Entelos, Inc., GlaxoSmithKline, Johnson and Johnson, March of Dimes Foundation, Merck and Company, Pfizer, Inc., Schering-Plough Research Institute, and UnitedHealth Group. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13: 978-0-309-10738-9 International Standard Book Number-10: 0-309-10738-5 Additional copies of this report are available from the National Academies Press, 500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap. edu. For more information about the Institute of Medicine, visit the IOM hom